IMCD

ACCE thesis

IMCD distributes specialty chemicals and food ingredients across Europe, Americas, and Asia-Pacific, serving over 50,000 customers through technical expertise and local market knowledge. The company operates in a fragmented $300 billion global specialty chemicals distribution market where scale economics and technical service capabilities create defensive moats around customer relationships. Management has executed 75+ acquisitions since 2000, systematically consolidating regional markets while expanding geographic reach and product portfolios. IMCD generates consistent mid-to-high single digit organic growth with EBITDA margins around 8-9%, benefiting from the structural shift toward outsourced distribution as chemical producers focus on core manufacturing. The stock trades at reasonable multiples despite delivering 15%+ annual EPS growth over the past five years through disciplined M&A and market share gains.

• high
  Earnings collapse

  Earnings dropped 37.5% YoY despite only 1.5% revenue decline, indicating severe margin compression or cost issues.
• moderate
  Weak growth trajectory

  5-year revenue CAGR of only 1.3% shows minimal long-term growth in a specialty chemicals company.
• moderate
  Poor quality score

  ACCE quality score of 47/100 and growth score of 7/100 suggest underlying business quality concerns.

Snapshot